These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29255041)

  • 21. Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.
    Bajic G; van der Poel CE; Kuraoka M; Schmidt AG; Carroll MC; Kelsoe G; Harrison SC
    Sci Rep; 2019 Mar; 9(1):3492. PubMed ID: 30837606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent Requirement of Fc-Fcγ Receptor Interactions for
    Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
    Andrews SF; Cominsky LY; Shimberg GD; Gillespie RA; Gorman J; Raab JE; Brand J; Creanga A; Gajjala SR; Narpala S; Cheung CSF; Harris DR; Zhou T; Gordon I; Holman L; Mendoza F; Houser KV; Chen GL; Mascola JR; Graham BS; Kwong PD; Widge A; Dropulic LK; Ledgerwood JE; Kanekiyo M; McDermott AB
    Sci Transl Med; 2023 Apr; 15(692):eade4976. PubMed ID: 37075126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.
    Cho KJ; Hong KW; Kim SH; Seok JH; Kim S; Lee JH; Saelens X; Kim KH
    PLoS One; 2014; 9(2):e89803. PubMed ID: 24587046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.
    Rudneva IA; Kushch AA; Masalova OV; Timofeeva TA; Klimova RR; Shilov AA; Ignatieva AV; Krylov PS; Kaverin NV
    Viral Immunol; 2010 Apr; 23(2):181-7. PubMed ID: 20373998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two types of antibodies are induced by vaccination with A/California/2009 pdm virus: binding near the sialic acid-binding pocket and neutralizing both H1N1 and H5N1 viruses.
    Ohshima N; Kubota-Koketsu R; Iba Y; Okuno Y; Kurosawa Y
    PLoS One; 2014; 9(2):e87305. PubMed ID: 24505283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
    Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
    Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.
    Smatti MK; Nasrallah GK; Al Thani AA; Yassine HM
    Vaccine; 2020 Jan; 38(4):815-821. PubMed ID: 31735504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
    Bangaru S; Lang S; Schotsaert M; Vanderven HA; Zhu X; Kose N; Bombardi R; Finn JA; Kent SJ; Gilchuk P; Gilchuk I; Turner HL; García-Sastre A; Li S; Ward AB; Wilson IA; Crowe JE
    Cell; 2019 May; 177(5):1136-1152.e18. PubMed ID: 31100268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly neutralizing antibodies target a haemagglutinin anchor epitope.
    Guthmiller JJ; Han J; Utset HA; Li L; Lan LY; Henry C; Stamper CT; McMahon M; O'Dell G; Fernández-Quintero ML; Freyn AW; Amanat F; Stovicek O; Gentles L; Richey ST; de la Peña AT; Rosado V; Dugan HL; Zheng NY; Tepora ME; Bitar DJ; Changrob S; Strohmeier S; Huang M; García-Sastre A; Liedl KR; Bloom JD; Nachbagauer R; Palese P; Krammer F; Coughlan L; Ward AB; Wilson PC
    Nature; 2022 Feb; 602(7896):314-320. PubMed ID: 34942633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
    Yamayoshi S; Yasuhara A; Ito M; Uraki R; Kawaoka Y
    J Clin Virol; 2018 Nov; 108():105-111. PubMed ID: 30292135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
    Darricarrère N; Qiu Y; Kanekiyo M; Creanga A; Gillespie RA; Moin SM; Saleh J; Sancho J; Chou TH; Zhou Y; Zhang R; Dai S; Moody A; Saunders KO; Crank MC; Mascola JR; Graham BS; Wei CJ; Nabel GJ
    Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of common epitopes on hemagglutinin of the influenza A virus (H1 subtype).
    Guo C; Xie X; Li H; Zhao P; Zhao X; Sun J; Wang H; Liu Y; Li Y; Hu Q; Hu J; Li Y
    Exp Mol Pathol; 2015 Feb; 98(1):79-84. PubMed ID: 25533547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.